Matthew R. Patterson, Chief Executive Officer at Audentes Therapeutics, Inc. (BOLD), sold 42,000 shares at $38.58 ($1.6M) on 2018-10-01, disclosed to the SEC on 2018-10-02.
Open-market sale of $1.6M BOLD by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.70 | 8,078 | $305K | 19.0% |
| 2 | $37.70 | 8,078 | $305K | 19.0% |
| 3 | $38.04 | 5,330 | $203K | 12.7% |
| 4 | $38.04 | 5,330 | $203K | 12.7% |
| 5 | $38.58 | 5,448 | $210K | 13.1% |
| 6 | $38.58 | 5,448 |
| $210K |
| 13.1% |
| 7 | $39.14 | 2,144 | $84K | 5.2% |
| 8 | $39.14 | 2,144 | $84K | 5.2% |
| Total | $38.16 avg | 42,000 | $1.6M | 100% |
| Filing → |
| BOLD | SELL | 2019-02-27 | $630K | — | Filing → |
| BOLD | SELL | 2018-09-20 | $518K | — | Filing → |
| BOLD | SELL | 2018-07-05 | $5.6M | — | Filing → |